Motilin, erythromycin, and the gastric migrating motor complex: Site of action

M. Nemanich, K. E. Behrns, M. G. Sarr

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Motilin is a putative hormone which induces a premature migrating motor complex when administered exogenously, but the target organ for this hormonal effect is undetermined. Our aim was to determine whether motilin and the motilin agonist, erythromycin, induce a premature migrating motor complex via an effect directly on the stomach. Six dogs underwent splenectomy and ligation of all branches of the splenic artery except the left gastroepiploic and short gastric arteries to the proximal stomach. An intraarterial catheter was placed in the proximal splenic artery for close intra-arterial injection of motilin and erythromycin directly to the gastric corpus/proximal antrum. After recovery, the minimum effective dose required to induce a premature migrating motor complex was determined for motilin and for erythromycin given close intra-arterially or intravenously (systemically) by monitoring upper gut myoelectric activity. Minimum effective doses of motilin and erythromycin were the same whether given intra-arterially or intravenously. The latency interval or the time to onset of a premature Phase III was less than 2 minutes for intraarterial or intravenous administration (P > 0.05). The characteristics of induced-Phase III activity (appearance, duration, velocity) did not differ from spontaneous Phase III activity (P > 0.05). Although plasma motilin concentrations increased after threshold doses of both motilin and erythromycin, increases in plasma motilin occurred later after erythromycin (10 min) than after exogenous motilin (3 min). Our findings suggest that motilin initiation of the migrating motor complex does not occur by independent stimulation of putative receptors in the gastric corpus or proximal antrum.

Original languageEnglish (US)
Pages (from-to)253-263
Number of pages11
JournalJournal of Gastrointestinal Motility
Volume5
Issue number4
StatePublished - 1993

Fingerprint

Migrating Myoelectric Complexes
Motilin
Erythromycin
Stomach
Splenic Artery
Intra-Arterial Injections
Splenectomy
Intravenous Administration
Ligation

Keywords

  • erythromycin
  • gastric motility
  • interdigestive motility
  • migrating motor complex

ASJC Scopus subject areas

  • Physiology
  • Gastroenterology

Cite this

Motilin, erythromycin, and the gastric migrating motor complex : Site of action. / Nemanich, M.; Behrns, K. E.; Sarr, M. G.

In: Journal of Gastrointestinal Motility, Vol. 5, No. 4, 1993, p. 253-263.

Research output: Contribution to journalArticle

Nemanich, M. ; Behrns, K. E. ; Sarr, M. G. / Motilin, erythromycin, and the gastric migrating motor complex : Site of action. In: Journal of Gastrointestinal Motility. 1993 ; Vol. 5, No. 4. pp. 253-263.
@article{fae386cdda104fc0853329c65c557d80,
title = "Motilin, erythromycin, and the gastric migrating motor complex: Site of action",
abstract = "Motilin is a putative hormone which induces a premature migrating motor complex when administered exogenously, but the target organ for this hormonal effect is undetermined. Our aim was to determine whether motilin and the motilin agonist, erythromycin, induce a premature migrating motor complex via an effect directly on the stomach. Six dogs underwent splenectomy and ligation of all branches of the splenic artery except the left gastroepiploic and short gastric arteries to the proximal stomach. An intraarterial catheter was placed in the proximal splenic artery for close intra-arterial injection of motilin and erythromycin directly to the gastric corpus/proximal antrum. After recovery, the minimum effective dose required to induce a premature migrating motor complex was determined for motilin and for erythromycin given close intra-arterially or intravenously (systemically) by monitoring upper gut myoelectric activity. Minimum effective doses of motilin and erythromycin were the same whether given intra-arterially or intravenously. The latency interval or the time to onset of a premature Phase III was less than 2 minutes for intraarterial or intravenous administration (P > 0.05). The characteristics of induced-Phase III activity (appearance, duration, velocity) did not differ from spontaneous Phase III activity (P > 0.05). Although plasma motilin concentrations increased after threshold doses of both motilin and erythromycin, increases in plasma motilin occurred later after erythromycin (10 min) than after exogenous motilin (3 min). Our findings suggest that motilin initiation of the migrating motor complex does not occur by independent stimulation of putative receptors in the gastric corpus or proximal antrum.",
keywords = "erythromycin, gastric motility, interdigestive motility, migrating motor complex",
author = "M. Nemanich and Behrns, {K. E.} and Sarr, {M. G.}",
year = "1993",
language = "English (US)",
volume = "5",
pages = "253--263",
journal = "Neurogastroenterology and Motility",
issn = "1350-1925",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Motilin, erythromycin, and the gastric migrating motor complex

T2 - Site of action

AU - Nemanich, M.

AU - Behrns, K. E.

AU - Sarr, M. G.

PY - 1993

Y1 - 1993

N2 - Motilin is a putative hormone which induces a premature migrating motor complex when administered exogenously, but the target organ for this hormonal effect is undetermined. Our aim was to determine whether motilin and the motilin agonist, erythromycin, induce a premature migrating motor complex via an effect directly on the stomach. Six dogs underwent splenectomy and ligation of all branches of the splenic artery except the left gastroepiploic and short gastric arteries to the proximal stomach. An intraarterial catheter was placed in the proximal splenic artery for close intra-arterial injection of motilin and erythromycin directly to the gastric corpus/proximal antrum. After recovery, the minimum effective dose required to induce a premature migrating motor complex was determined for motilin and for erythromycin given close intra-arterially or intravenously (systemically) by monitoring upper gut myoelectric activity. Minimum effective doses of motilin and erythromycin were the same whether given intra-arterially or intravenously. The latency interval or the time to onset of a premature Phase III was less than 2 minutes for intraarterial or intravenous administration (P > 0.05). The characteristics of induced-Phase III activity (appearance, duration, velocity) did not differ from spontaneous Phase III activity (P > 0.05). Although plasma motilin concentrations increased after threshold doses of both motilin and erythromycin, increases in plasma motilin occurred later after erythromycin (10 min) than after exogenous motilin (3 min). Our findings suggest that motilin initiation of the migrating motor complex does not occur by independent stimulation of putative receptors in the gastric corpus or proximal antrum.

AB - Motilin is a putative hormone which induces a premature migrating motor complex when administered exogenously, but the target organ for this hormonal effect is undetermined. Our aim was to determine whether motilin and the motilin agonist, erythromycin, induce a premature migrating motor complex via an effect directly on the stomach. Six dogs underwent splenectomy and ligation of all branches of the splenic artery except the left gastroepiploic and short gastric arteries to the proximal stomach. An intraarterial catheter was placed in the proximal splenic artery for close intra-arterial injection of motilin and erythromycin directly to the gastric corpus/proximal antrum. After recovery, the minimum effective dose required to induce a premature migrating motor complex was determined for motilin and for erythromycin given close intra-arterially or intravenously (systemically) by monitoring upper gut myoelectric activity. Minimum effective doses of motilin and erythromycin were the same whether given intra-arterially or intravenously. The latency interval or the time to onset of a premature Phase III was less than 2 minutes for intraarterial or intravenous administration (P > 0.05). The characteristics of induced-Phase III activity (appearance, duration, velocity) did not differ from spontaneous Phase III activity (P > 0.05). Although plasma motilin concentrations increased after threshold doses of both motilin and erythromycin, increases in plasma motilin occurred later after erythromycin (10 min) than after exogenous motilin (3 min). Our findings suggest that motilin initiation of the migrating motor complex does not occur by independent stimulation of putative receptors in the gastric corpus or proximal antrum.

KW - erythromycin

KW - gastric motility

KW - interdigestive motility

KW - migrating motor complex

UR - http://www.scopus.com/inward/record.url?scp=0027332460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027332460&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0027332460

VL - 5

SP - 253

EP - 263

JO - Neurogastroenterology and Motility

JF - Neurogastroenterology and Motility

SN - 1350-1925

IS - 4

ER -